Governing antibiotic resistance through One Health: Insights from the political and legal landscape in Senegal
Mouhamadou Moustapha Sow, Léo Delpy, Mamadou Ciss, Assane Gueye Fall, Nicolas Djighnoum Diouf, Jean-Hugues Caffin, Ndeye Mery Dia, Marion Bordier, Giorgia Sulis, Giorgia Sulis

TL;DR
This paper examines how Senegal is tackling antibiotic resistance through a One Health approach, highlighting challenges like weak legal frameworks and the need for better funding and collaboration.
Contribution
The study provides a novel analysis of Senegal's One Health governance for antibiotic resistance, identifying systemic barriers and proposing context-sensitive policy improvements.
Findings
Senegal's One Health platform lacks formalization and resources, limiting its effectiveness.
Outdated legal frameworks and poor rural infrastructure hinder antibiotic resistance management.
Power imbalances and weak surveillance systems impede collective action and data-sharing.
Abstract
Antimicrobial resistance (AMR), especially antibiotic resistance (ABR), could cause up to 10 million deaths per year by 2050. While ABR is a natural phenomenon, it is exacerbated by antibiotic misuse, poor sanitation, insufficient health infrastructure, weak biosecurity, and environmental contamination. The cross-transmission of resistant bacteria between humans, animal and the environment requires a multi-sectoral response inspired by the One Health concept. With the support of international partners and in line with global policies, Senegal has established a national One Health platform and legal measures to combat ABR. Our study proposes to examine the One Health governance capacities for managing ABR in Senegal, and to identify ways of improvement from a One Health perspective. A qualitative approach was adopted, combining the review of 64 legal instruments and 26 semi-structured…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsAntibiotic Use and Resistance · Zoonotic diseases and public health · Pharmaceutical and Antibiotic Environmental Impacts
